The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer

Diseases of the Colon and Rectum

Volumn 57, Issue 9, 2014, Pages 1049-1058

  Yun, Jung A ^a   Huh, Jung Wook ^a   Park, Yoon Ah ^a   Cho, Yong Beom ^a   Yun, Seong Hyeon ^a   Kim, Hee Cheol ^a   Lee, Woo Yong ^a   Chun, Ho Kyung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Chemotherapy; Colorectal cancer; Primary tumor; Resection; Unresectable metastases

Indexed keywords

FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; ASYMPTOMATIC PRIMARY TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ASSESSMENT; COLORECTAL CANCER; COLORECTAL SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERITONEUM METASTASIS; PRIMARY TUMOR; PROGNOSTIC ASSESSMENT; PROPENSITY SCORE; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; COLORECTAL TUMOR; METASTASIS; MORTALITY; PALLIATIVE THERAPY; PATHOLOGY; PERITONEUM TUMOR; POSTOPERATIVE COMPLICATION; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROPENSITY SCORE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84907285179     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0000000000000193     Document Type: Article

References (23)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
2. Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat. 2012;44:11-24.
3. Ries LA G, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute; 2008. Available at: http://seer.cancer.gov/csr/1975-2005, based on November 2007 SEER data submission, posted to the SEER website. Accessed November 22, 2013.
4. Kim YW, Kim IY. The role of surgery for asymptomatic primary tumors in unresectable stage IV colorectal cancer. Ann Coloproctol. 2013;29:44-54.
5. Bacon HE, Martin PV. The rationale of palliative resection for primary cancer of the colon and rectum complicated by liver and lung metastasis. Dis Colon Rectum. 1964;7:211-217.
6. Joffe J, Gordon PH. Palliative resection for colorectal carcinoma. Dis Colon Rectum. 1981;24:355-360.
7. Mäkelä J, Haukipuro K, Laitinen S, Kairaluoma MI. Palliative operations for colorectal cancer. Dis Colon Rectum. 1990;33:846-850.
8. Galizia G, Lieto E, Orditura M, et al. First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg. 2008; 143: 352-358.
9. Law WL, Chu KW. Outcomes of resection of stage IV rectal cancer with mesorectal excision. J Surg Oncol. 2006;93:523-528.
10. Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg. 2005;92:1155-1160.
11. Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol. 1999;6:651-657.
12. Tebbutt NC, Norman AR, Cunningham D, et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut. 2003;52:568-573.
13. McCahill LE, Yothers G, Sharif S, et al. Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10. J Clin Oncol. 2012;30:3223-3228.
14. Ferrand F, Malka D, Bourredjem A, et al. Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601. Eur J Cancer. 2013;49:90-97.
15. Seo GJ, Park JW, Yoo SB, et al. Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage IV colorectal cancer. J Surg Oncol. 2010;102:94-99.
16. Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg. 2003;196:722-728.
17. Huh JW, Lee WY, Park YA, et al. Prognostic factors associated with primary cancer in curatively resected stage IV colorectal cancer. J Cancer Res Clin Oncol. 2014;140:435-441.
18. Bajwa A, Blunt N, Vyas S, et al. Primary tumour resection and survival in the palliative management of metastatic colorectal cancer. Eur J Surg Oncol. 2009;35:164-167.
19. Venderbosch S, de Wilt JH, Teerenstra S, et al. Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature. Ann Surg Oncol. 2011;18:3252-3260.
20. Yun HR, Lee WY, Lee WS, Cho YB, Yun SH, Chun HK. The prognostic factors of stage IV colorectal cancer and assessment of proper treatment according to the patient's status. Int J Colorectal Dis. 2007; 22:1301-1310.
21. Michel P, Roque I, Di Fiore F, et al. Colorectal cancer with nonresectable synchronous metastases: should the primary tumor be resected? Gastroenterol Clin Biol. 2004;28:434-437.
22. Yoon YS, Kim CW, Lim SB, et al. Palliative surgery in patients with unresectable colorectal liver metastases: a propensity score matching analysis. J Surg Oncol. 2014;109:239-244.
23. Saunders TH, Mendes Ribeiro HK, Gleeson FV. New techniques for imaging colorectal cancer: the use of MRI, PET and radioimmunoscintigraphy for primary staging and follow-up. Br Med Bull. 2002;64:81-99.